You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 135 No. 6, June 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Critical Situations: Dermatology in the Acute Care Setting
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dermatology
 •Dermatologic Disorders
 •Connective Tissue Diseases
 •Cardiovascular System
 •Rheumatology
 •Rheumatoid Arthritis
 •Cardiovascular Disease/ Myocardial Infarction
 •Dermatology, Other
 •Immunology
 •Immunologic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Purple Toes in a Patient With End-Stage Rheumatoid Arthritis

Hossein C. Nousari, MD; Arash Kimyai-Asadi, MD; Justin Stebbing, MD, MRCP; John H. Stone, MD, MPH

Arch Dermatol. 1999;135:648-650.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

REPORT OF A CASE

A 57-year-old Puerto Rican woman was admitted with a 4-week history of painful, purple toes associated with malaise, fevers, sweats, and intermittent discomfort in the middle part of her chest. She had initially presented to an outside hospital, where blood cultures, a transthoracic echocardiogram, and an angiogram of the lower abdominal aorta with runoff revealed no abnormalities. However, it was concluded that she had had thromboembolic events to her toes, and warfarin therapy was initiated. She presented to our institution 2 weeks later with worsening pain and moderate expansion of the ischemic area.

The patient's medical history was significant for deforming rheumatoid arthritis (RA) of 30 year's duration, meeting the American College of Rheumatology criteria for RA. She had been treated with tapering courses of prednisone starting at a dose of 60 mg/d, weekly . . . [Full Text of this Article]

COMMENT

From the Division of Dermatoimmunology, Department of Dermatology (Drs Nousari and Kimyai-Asadi), and the Division of Rheumatology, Department of Medicine (Drs Stebbing and Stone), Johns Hopkins Medical Institutions, Baltimore, Md



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.